Details for New Drug Application (NDA): 018828
✉ Email this page to a colleague
The generic ingredient in ZOVIRAX is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for 018828
Tradename: | ZOVIRAX |
Applicant: | Norvium Bioscience |
Ingredient: | acyclovir |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018828
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jan 25, 1985 | TE: | RLD: | Yes |
Expired US Patents for NDA 018828
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norvium Bioscience | ZOVIRAX | acyclovir | CAPSULE;ORAL | 018828-001 | Jan 25, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription